年轻女性生殖健康与晚年心血管疾病关联的伞状综述
该伞状综述汇总系统综述与荟萃分析,评估育龄女性生殖因素与后续心血管疾病风险的关联。共纳入32篇综述,平均随访7-10年。子痫前期、死产和早产与复合心血管疾病风险约两倍相关;较长哺乳期与心血管疾病风险降低相关。若关联为因果,可解释女性心血管疾病的大部分不明风险。
要点
- 子痫前期、死产、早产与复合心血管疾病风险约两倍相关。
- 子痫前期与心力衰竭风险四倍相关。
- 较长哺乳期与心血管疾病风险降低相关。
核心结论
- 从初潮到绝经,生殖因素与女性心血管疾病相关。
- 若这些关联为因果,可解释女性心血管疾病的大部分不明风险,且风险可能可改变。
- 政策制定者应考虑将生殖风险因素纳入临床指南的心血管风险评估。
研究设计与样本
- 伞状综述,检索Medline、Embase和Cochrane数据库从建库至2019年8月31日的系统综述与荟萃分析。
- 由两名独立评审员进行筛选、数据提取和质量评价。
- 纳入32篇综述,评估多种风险因素,平均随访7-10年;除三篇外均为中等质量。
- 采用叙述性证据综合,辅以森林图和表格呈现。
主要发现
- 复合心血管疾病关联:子痫前期、死产和早产为两倍;妊娠期高血压、胎盘早剥、妊娠期糖尿病和早发性卵巢功能不全为1.5-1.9倍;早初潮、多囊卵巢综合征、曾生育和早绝经小于1.5倍。
- 缺血性心脏病关联:子痫前期、复发性子痫前期、妊娠期糖尿病和早产为两倍或以上;当前使用复方口服避孕药(雌激素和孕激素)、复发性流产、早发性卵巢功能不全和早绝经为1.5-1.9倍;流产、多囊卵巢综合征和绝经症状小于1.5倍。
- 卒中结局关联:当前使用任何口服避孕药(复方口服避孕药或仅孕激素片)、子痫前期和复发性子痫前期为两倍或以上;当前使用复方口服避孕药、妊娠期糖尿病和早产为1.5-1.9倍;多囊卵巢综合征小于1.5倍。
- 子痫前期与心力衰竭关联为四倍。
- 较长哺乳期与心血管疾病风险降低相关;当前使用仅孕激素避孕药、使用非口服激素避孕药或生育治疗与心血管疾病结局无关联。
关键数值与推荐
- 复合心血管疾病:子痫前期、死产、早产OR约2;妊娠期高血压、胎盘早剥、妊娠期糖尿病、早发性卵巢功能不全OR 1.5-1.9。
- 缺血性心脏病:子痫前期、复发性子痫前期、妊娠期糖尿病、早产OR≥2;当前使用复方口服避孕药、复发性流产、早发性卵巢功能不全、早绝经OR 1.5-1.9。
- 卒中:当前使用任何口服避孕药、子痫前期、复发性子痫前期OR≥2;当前使用复方口服避孕药、妊娠期糖尿病、早产OR 1.5-1.9。
- 心力衰竭:子痫前期OR约4。
临床怎么用
- 在女性生命早期识别生殖风险因素,可能有助于启动策略以改变潜在风险。
- 临床指南应考虑将生殖风险因素纳入女性心血管风险评估。
局限性
- 无法在本综述中呈现问题规模的绝对数值。
- 除三篇综述外,其余均为中等质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To consolidate evidence from systematic reviews and meta-analyses investigating the association between reproductive factors in women of reproductive age and their subsequent risk of cardiovascular disease. DESIGN: Umbrella review. DATA SOURCES: Medline, Embase, and Cochrane databases for systematic reviews and meta-analyses from inception until 31 August 2019. REVIEW METHODS: Two independent reviewers undertook screening, data extraction, and quality appraisal. The population was women of reproductive age. Exposures were fertility related factors and adverse pregnancy outcomes. Outcome was cardiovascular diseases in women, including ischaemic heart disease, heart failure, peripheral arterial disease, and stroke. RESULTS: 32 reviews were included, evaluating multiple risk factors over an average follow-up period of 7-10 years. All except three reviews were of moderate quality. A narrative evidence synthesis with forest plots and tabular presentations was performed. Associations for composite cardiovascular disease were: twofold for pre-eclampsia, stillbirth, and preterm birth; 1.5-1.9-fold for gestational hypertension, placental abruption, gestational diabetes, and premature ovarian insufficiency; and less than 1.5-fold for early menarche, polycystic ovary syndrome, ever parity, and early menopause. A longer length of breastfeeding was associated with a reduced risk of cardiovascular disease. The associations for ischaemic heart disease were twofold or greater for pre-eclampsia, recurrent pre-eclampsia, gestational diabetes, and preterm birth; 1.5-1.9-fold for current use of combined oral contraceptives (oestrogen and progesterone), recurrent miscarriage, premature ovarian insufficiency, and early menopause; and less than 1.5-fold for miscarriage, polycystic ovary syndrome, and menopausal symptoms. For stroke outcomes, the associations were twofold or more for current use of any oral contraceptive (combined oral contraceptives or progesterone only pill), pre-eclampsia, and recurrent pre-eclampsia; 1.5-1.9-fold for current use of combined oral contraceptives, gestational diabetes, and preterm birth; and less than 1.5-fold for polycystic ovary syndrome. The association for heart failure was fourfold for pre-eclampsia. No association was found between cardiovascular disease outcomes and current use of progesterone only contraceptives, use of non-oral hormonal contraceptive agents, or fertility treatment. CONCLUSIONS: From menarche to menopause, reproductive factors were associated with cardiovascular disease in women. In this review, presenting absolute numbers on the scale of the problem was not feasible; however, if these associations are causal, they could account for a large proportion of unexplained risk of cardiovascular disease in women, and the risk might be modifiable. Identifying reproductive risk factors at an early stage in the life of women might facilitate the initiation of strategies to modify potential risks. Policy makers should consider incorporating reproductive risk factors as part of the assessment of cardiovascular risk in clinical guidelines. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42019120076.
引用
- Okoth K, Chandan JS, Marshall T, et al. Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review. BMJ. 2020. PMID: 33028606. doi:10.1136/bmj.m3502
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。